Search - tctmd.com

Displaying 441 - 460 of 474

Sort: Relevancy | Date

News Industry News

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

November 09, 2011

News Industry News

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

November 08, 2011

News Industry News

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

November 08, 2011

News Industry News

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

November 08, 2011

News Industry News

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

November 08, 2011

News Industry News

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

November 08, 2011

News Industry News

Clinical trial comparing Prasurgrel to Clopidogrel following percutaneous coronary intervention is ended early

November 08, 2011

News Industry News

Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery

November 08, 2011

News Daily News

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Jason Kahn

August 01, 2011

News Daily News

Study Examines Predictors of Thrombus Aspiration Failure in Primary PCI

June 22, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

Survey Exposes Conflicted Attitudes Toward Industry Funding of CME

Caitlin E. Cox

May 13, 2011

News Daily News

Guideline-Based Treatments Linked to Improved Survival for STEMI Patients

April 27, 2011

News Daily News

Single-Center Experience Shows Evolution of CoreValve Procedure Over Time

Jason Kahn

April 18, 2011

News Conference News

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Caitlin E. Cox

April 05, 2011

News Daily News

Clinicians Agree Overall with Appropriateness Criteria, with Some Caveats

March 28, 2011

News Industry News

SCAI Announces its Inaugural Class of Emerging Leader Mentorship Fellows

February 06, 2011

News Industry News

Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar

January 18, 2011

News Industry News

Merck Statement on Changes to Clinical Studies of Vorapaxar

January 12, 2011

News Daily News

Consensus TAVI Endpoint Definitions Raise Standard of Research in New Field

January 11, 2011

Advertisement

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

Clinical trial comparing Prasurgrel to Clopidogrel following percutaneous coronary intervention is ended early

Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Study Examines Predictors of Thrombus Aspiration Failure in Primary PCI

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

Survey Exposes Conflicted Attitudes Toward Industry Funding of CME

Guideline-Based Treatments Linked to Improved Survival for STEMI Patients

Single-Center Experience Shows Evolution of CoreValve Procedure Over Time

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Clinicians Agree Overall with Appropriateness Criteria, with Some Caveats

SCAI Announces its Inaugural Class of Emerging Leader Mentorship Fellows

Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar

Merck Statement on Changes to Clinical Studies of Vorapaxar

Consensus TAVI Endpoint Definitions Raise Standard of Research in New Field

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content